ER alpha/NR3A1 Antibody - BSA Free Summary
| Description |
This antibody can be used as the primary antibody in a PLA assay with the following as complementing antibodies:NB500-158, NB100-1567, NB100-58824, NB100-97831, NB200-171, NB100-2254, NB100-58826, NB600-233, NB100-314, NB100-77315, NB100-77315 |
| Immunogen |
The immunogen recognized by this antibody maps to a region between residue 550 and the C-terminus (residue 595) of human Estrogen Receptor Alpha using the numbering given in SwissProt entry P03372 (GeneID 2099). |
| Isotype |
IgG |
| Clonality |
Polyclonal |
| Host |
Rabbit |
| Gene |
ESR1 |
| Purity |
Immunogen affinity purified |
| Innovator's Reward |
Test in a species/application not listed above to receive a full credit towards a future purchase. |
Applications/Dilutions
| Dilutions |
- Immunoprecipitation 2-10 ug/mg lysate
- Western Blot 1:5000-1:15000
|
| Theoretical MW |
66 kDa. Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors. |
| Control |
|
| Publications |
|
Packaging, Storage & Formulations
| Storage |
Store at 4C. Do not freeze. |
| Buffer |
Tris-Citrate/Phosphate (pH 7.0 - 8.0) |
| Preservative |
0.09% Sodium Azide |
| Concentration |
1.0 mg/ml |
| Purity |
Immunogen affinity purified |
Notes
This antibody can be used as the primary antibody in a PLA assay with the following as complementing antibodies:NB500-158, NB100-1567, NB100-58824, NB100-97831, NB200-171, NB100-2254, NB100-58826, NB600-233, NB100-314, NB100-77315, NB100-77315
Alternate Names for ER alpha/NR3A1 Antibody - BSA Free
Background
The estrogen receptor (ESR) is a ligand-activated transcription factor composed of several domains important for hormone binding, DNA binding, and activation of transcription. Alternative splicing results in several ESR1 mRNA transcripts, which differ primarily in their 5-prime untranslated regions. The translated receptors show less variability.[supplied by OMIM]
Limitations
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are
guaranteed for 1 year from date of receipt.
Customers Who Viewed This Item Also Viewed...
Species: Hu
Applications: ICC, IHC, Simple Western, WB
Species: Hu
Applications: ELISA
Species: Hu, Pm, Mu
Applications: ChIP, DB, Flow, ICC/IF, IHC, IHC-Fr, IHC-P, IP, Simple Western, WB
Species: Hu
Applications: BA
Species: Hu
Applications: ELISA, AP, PA, PAGE, WB
Species: Hu
Applications: ICC/IF, IHC, IHC-P
Species: Hu, Mu, Rt
Applications: WB
Species: Hu, Mu, Rt
Applications: ICC/IF, IHC, IHC-P, WB
Species: Ca, Hu, Mu, Pm, Rt
Applications: IHC, IHC-P, WB
Species: Hu
Applications: CyTOF-ready, Dual ISH-IHC, ELISA(Cap), ELISA(Det), ELISA(Sta), Flow, ICC, IHC, IP, Simple Western, WB
Species: Hu, Mu, Pm, Rb, Rt
Applications: ICC/IF, IHC, IHC-P, Simple Western, WB
Species: Hu, Mu, Rt, Xp(-), Ye
Applications: CyTOF-ready, ELISA, Flow-IC, Flow, ICC/IF, IHC, IHC-Fr, IHC-P, IP, WB
Species: Hu
Applications: BA
Species: Mu
Applications: ELISA
Species: Hu
Applications: ICC, IHC, Neut, WB
Species: Hu
Applications: ICC/IF, IHC, IHC-P
Species: Hu
Applications: ICC/IF, IHC, IHC-P, WB
Species: Hu
Applications: BA
Publications for ER alpha/NR3A1 Antibody (NB200-347)(5)
Showing Publications 1 -
5 of 5.
| Publications using NB200-347 |
Applications |
Species |
| Ha NH, Nair VS, Reddy DN et al. Lactoferrin-endothelin-1 axis contributes to the development and invasiveness of triple-negative breast cancer phenotypes. Cancer Res 2011-12-01 [PMID: 22006997] |
|
|
| Di Leva G, Gasparini P, Piovan C et al. MicroRNA cluster 221-222 and estrogen receptor alpha interactions in breast cancer. J Natl Cancer Inst 2010-05-01 [PMID: 20388878] |
|
|
| Ohshiro K, Mudvari P, Meng QC et al. Identification of a novel estrogen receptor-alpha variant and its upstream splicing regulator. Mol Endocrinol 2010-05-01 [PMID: 20304996] |
|
|
| Popov VM, Zhou J, Shirley LA et al. The cell fate determination factor DACH1 is expressed in estrogen receptor-alpha-positive breast cancer and represses estrogen receptor-alpha signaling. Cancer Res 2009-07-01 [PMID: 19605405] |
|
|
| Zheng X, Chu F, Chou PM et al. Cathepsin L inhibition suppresses drug resistance in vitro and in vivo: a putative mechanism. Am J Physiol Cell Physiol 2009-01-01 [PMID: 18971393] |
|
|
Reviews for ER alpha/NR3A1 Antibody (NB200-347) (0)
There are no reviews for ER alpha/NR3A1 Antibody (NB200-347).
By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
- Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
- Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen
Product General Protocols
Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.
Video Protocols
FAQs for ER alpha/NR3A1 Antibody (NB200-347) (0)
Control Lysate(s)
Secondary Antibodies
| |
Isotype Controls
|
Additional ER alpha/NR3A1 Products
Research Areas for ER alpha/NR3A1 Antibody (NB200-347)
Find related products by research area.
|
Blogs on ER alpha/NR3A1